RII retinamide

Drug Profile

RII retinamide

Latest Information Update: 08 Aug 2007

Price : $50

At a glance

  • Originator Chinese Academy of Medical Sciences
  • Class Antineoplastics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Preleukaemia

Most Recent Events

  • 01 Feb 2000 Suspended-Registered for Preleukaemia in China (Topical)
  • 01 Feb 2000 Suspended-II for Preleukaemia in USA (PO)
  • 01 Feb 2000 Suspended-Registered for Preleukaemia in China (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top